Australian Clinical Labs (ASX:ACL) ROE % Adjusted to Book Value : 1.67% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs ROE % Adjusted to Book Value?

Australian Clinical Labs's ROE % for the quarter that ended in Dec. 2023 was 5.87%. Australian Clinical Labs's PB Ratio for the quarter that ended in Dec. 2023 was 3.52. Australian Clinical Labs's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 1.67%.

Australian Clinical Labs ROE % Adjusted to Book Value Historical Data

The historical data trend for Australian Clinical Labs's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs ROE % Adjusted to Book Value Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

11.18

28.49

4.40

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			29.98	10.97	7.32	3.00	1.67

Competitive Comparison of Australian Clinical Labs's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Australian Clinical Labs's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Australian Clinical Labs's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Australian Clinical Labs's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Australian Clinical Labs's ROE % Adjusted to Book Value falls into.

Australian Clinical Labs ROE % Adjusted to Book Value Calculation

Australian Clinical Labs's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	17.73%	/	4.03
	=	4.40%

Australian Clinical Labs's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	5.87%	/	3.52
	=	1.67%

Australian Clinical Labs ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines